UroGen Pharma Ltd.

NASDAQ:URGN

Biotechnology

Healthcare
$29.79 -1.22%

-$0.40 today

Market cap
$1.46B
Beta
1.62
P/E (TTM)
-12.2
EPS (TTM)
-$2.65
52W Low $12.73High $33.79

Volume 1.14M

Average 0.79M

Balance Sheet

Inspect the capital base behind the business.

Assets

$200.46M

FY 2025 · Annual

-29.8% YoY

Liabilities

$305.93M

FY 2025 · Annual

+3.9% YoY

Equity

-$105.47M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents44.36M55.41M95M171.99M110.75M
Short-term Investments44.78M44.56M41.97M64.7M9.71M
Net Receivables11.72M12.7M15.44M20.3M33.08M
Inventory4.83M4.33M5.67M9.23M16.46M
Other Current Assets1.23M11.91M11.1M9.92M16.02M
Total Current Assets114.39M128.91M169.19M276.14M186.02M
Property, Plant & Equipment (Net)3.15M3.75M2.36M3.79M9.09M
Goodwill00000
Intangible Assets00000
Long-term Investments675K04.5M5.02M177K
Tax Assets00000
Other Non-current Assets1.53M2.96M2.26M765K5.16M
Total Non-current Assets5.36M6.71M9.13M9.58M14.43M
Total Assets119.75M135.62M178.31M285.71M200.46M
Account Payables5.79M5.53M6.51M10.93M12.14M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities10.28M11.53M14.67M18.52M18.7M
Total Current Liabilities22.38M23.92M31.21M45.95M46.42M
Long-term Debt097.54M98.55M121.73M122.21M
Deferred Tax Liabilities2.84M3.02M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities85.71M98.92M112.92M125.18M131.18M
Total Non-current Liabilities88.95M201.06M212.31M248.57M259.51M
Total Liabilities111.33M224.98M243.52M294.51M305.93M
Common Stock61K63K89K115K133K
Retained Earnings(467.32M)(577.1M)(679.35M)(806.22M)(959.72M)
Accumulated OCI(25K)(107K)12K56K19K
Other Stockholders Equity00000
Minority Interest00000
Total Equity8.41M(89.36M)(65.21M)(8.8M)(105.47M)
Total Debt398K99.12M99.4M123.39M128.33M
Net Debt(43.96M)43.72M4.39M(48.6M)17.59M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$111.3M
Short-term Investments$30.3M
Receivables$55.4M
Inventory$20.9M
Other Current$19.5M
Total Current Assets$237.5M
PP&E (Net)$8.6M
Long-term Investments$177.0K
Other Non-current$7.5M
Total Non-current Assets$16.2M
Total Assets$253.7M

Analysis

Selected assets total $253.7M for Latest. The largest visible component is Cash & Equivalents at $111.3M, about 43.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
S-8S-8 filingNov 4, 2026
SC 13G/ASC 13G/A filingOct 27, 2026

How much cash does URGN have?

UroGen Pharma Ltd. (URGN) reported $110.75M in cash and equivalents in fiscal 2025.

How much debt does URGN carry?

UroGen Pharma Ltd. (URGN) reported $128.33M of total debt, with net debt of $17.59M.